Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
revefenacin muscarinic acetylcholine receptor small molecule NA drugbank , DGIDB Solutions[MeSHID:D012996]
Disease[MeSHID:D004194]
Maintenance[MeSHID:D008283]
Cause of Death[MeSHID:D002423]
Chronic Obstructive Airway Disease[MeSHID:D029424]
Inspiration function[MeSHID:D001239]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.46 approved,investigational antagonist
revefenacin muscarinic acetylcholine receptor small molecule NA drugbank , DGIDB Solutions[MeSHID:D012996]
Disease[MeSHID:D004194]
Maintenance[MeSHID:D008283]
Cause of Death[MeSHID:D002423]
Chronic Obstructive Airway Disease[MeSHID:D029424]
Inspiration function[MeSHID:D001239]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.15 approved,investigational antagonist
revefenacin muscarinic acetylcholine receptor small molecule NA drugbank , DGIDB Solutions[MeSHID:D012996]
Disease[MeSHID:D004194]
Maintenance[MeSHID:D008283]
Cause of Death[MeSHID:D002423]
Chronic Obstructive Airway Disease[MeSHID:D029424]
Inspiration function[MeSHID:D001239]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.13 approved,investigational antagonist
revefenacin muscarinic acetylcholine receptor small molecule NA drugbank , DGIDB Solutions[MeSHID:D012996]
Disease[MeSHID:D004194]
Maintenance[MeSHID:D008283]
Cause of Death[MeSHID:D002423]
Chronic Obstructive Airway Disease[MeSHID:D029424]
Inspiration function[MeSHID:D001239]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.22 approved,investigational antagonist
revefenacin muscarinic acetylcholine receptor small molecule NA drugbank , DGIDB Solutions[MeSHID:D012996]
Disease[MeSHID:D004194]
Maintenance[MeSHID:D008283]
Cause of Death[MeSHID:D002423]
Chronic Obstructive Airway Disease[MeSHID:D029424]
Inspiration function[MeSHID:D001239]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.2 approved,investigational antagonist
click here to return to the previous page